Product Information
MOMETASONE FUROATE 0.1% CREAM is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $0.4202 per GM under NDC 00713063415. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 22, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/g
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713063415
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
MOMETASONE FUROATEApproval Type
Generic (ANDA)
FDA Application
ANDA077447FDA Approved
5/22/2006
TE Code
AB
On Market Since
8/23/2006
Pharmacological Classes
Price Statistics
The NADAC for MOMETASONE FUROATE 0.1% CREAM has been published 671 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4202 per GM |
|---|---|
| All-time high | $0.8974 (Mar 13, 2019) |
| All-time low | $0.3064 (Apr 18, 2018) |
| 52-week high | $0.4546 |
| 52-week low | $0.4076 |
| Median price | $0.4533 |
| Average price | $0.4717 |
| Largest weekly change | +32.4% (Jun 19, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cosette Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mometasone Furoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MOMETASONE FUROATE 0.1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% CREAM, manufactured by Cosette Pharmaceuticals, Inc., is $0.4202 per GM (NDC 00713063415), effective Sep 30, 2026.
How has the price of MOMETASONE FUROATE 0.1% CREAM changed over time?
Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% CREAM has held within roughly two percent of its current level. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% CREAM?
Since Nov 28, 2013, the NADAC for MOMETASONE FUROATE 0.1% CREAM has ranged from a low of $0.3064 (Apr 18, 2018) to a high of $0.8974 (Mar 13, 2019), with a median of $0.4533 per GM.
Are there cheaper alternatives to MOMETASONE FUROATE 0.1% CREAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MOMETASONE FUROATE 0.1% CREAM, is $0.2959 per GM — about 30% below MOMETASONE FUROATE 0.1% CREAM.
Who manufactures MOMETASONE FUROATE 0.1% CREAM?
MOMETASONE FUROATE 0.1% CREAM (NDC 00713063415) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.